Latest Monoclonal Antibody Treatment Approved for High-Risk Patients - The New York Times

Latest Monoclonal Antibody Treatment Approved for High-Risk Patients - The New York Times: The drug, from GlaxoSmithKline and Vir, aims to keep those who have contracted the disease out of the hospital.